Serial Entrepreneur, C-Level Executive, and Scientist developing advanced wound care products for the past 30 years with 15 peer reviewed publications and 45 world-wide patents.  Dr. Sanders was founder and CEO of ECI Biotech (1998-2016) and his company developed the first infection diagnostic for chronic wounds (Bacterial Status), sold by WoundChek Labs.  Dr. Sanders is currently the Chief Scientific Officer of Alira Health, and Executive Vice President of the Product Development Lab. Over the past 20 years Dr. Sanders has secured over $50M in strategic partnerships for new product development. Dr. Sanders earned his undergraduate degree in Biology from Boston University, followed by a MS and PhD in Biology and Biomedical Sciences at Worcester Polytechnic Institute (WPI). His postdoctoral training was at MIT/Whitehead Institute in Biochemistry and Host Pathogen Interactions.